DNM1L and triple-A syndrome: Western blotting results also showed that miR-19b-3p-AMEXO treatment significantly reduced the expression level of MST4, p-ERK and p-Drp1 (ser616) in the aortic tissue of AAA mice compared with AMEXO treatment (Fig. 8G).